BioCentury | Sep 23, 2020
Deals

Sept. 22 Quick Takes: Celgene CVR still in play; plus Dr. Reddy’s in Sputnik deal, $30M for Siolta, Amgen-Lilly, BioNTech-Novartis, Genentech-Scenic

...areas. Amsterdam-based Scenic, which is led by CEO Oscar Izeboud and spun out of the Netherlands Cancer Institute...
BioCentury | Sep 15, 2020
Finance

Cell therapy play Neogene’s $110M series A marks first investment for Tordjman’s Jeito Capital

...Vida, where Chang is an adviser. Linnemann, Neogene’s CEO, and Schumacher, who is a principal investigator at the Netherlands Cancer Institute...
BioCentury | Feb 22, 2019
Targets & Mechanisms

Expansion into TNBC

...if earlier examples carried the same risk. A 2018 study from a group at the Netherlands Cancer Institute...
...Francisco, Calif. Genmab A/S (CSE:GEN; Pink:GMXAY), Copenhagen, Denmark Merck & Co Inc. (NYSE:MRK), Kenilworth, N.J. Netherlands Cancer Institute...
BioCentury | Jan 9, 2019
Translation in Brief

T cells: Life after exhaustion?

...Weizmann Institute of Science and Netherlands Cancer Institute (NKI) scientists have shown dysfunctional T cells are not as...
...with high tumor reactivity. "We should not consider these cells inactive." Anne van der Leun, Netherlands Cancer Institute...
...CD274) - Programmed cell death 1 ligand 1; T cell receptor (TCR) Chris Lieu, Staff Writer Merck KGaA Netherlands Cancer Institute Weizmann...
BioCentury | Dec 20, 2018
Translation in Brief

Beyond T cell counts

...been focused on boosting overall T cell count in the tumor microenvironment, researchers at the Netherlands Cancer Institute...
...TCR profiling helps you to understand what the bottleneck is in tumor control.” Ton Schumacher, Netherlands Cancer Institute...
...tumor-reactive TCRs changes following treatment with immunotherapy. Schumacher said the work is unpatented. Alicia Parker, Staff Writer Netherlands Cancer Institute T...
BioCentury | Jun 7, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2018

...suggest inhibiting KREMEN1 alone or in combination with KREMEN2 could help treat coxsackie viral infections. Netherlands Cancer Institute...
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...the Netherlands Cell-seq mutagenesis screening platform to identify drug targets in a human cell line Netherlands Cancer Institute...
BioCentury | May 1, 2018
Distillery Therapeutics

Infectious disease

...online April 19, 2018 doi:10.1016/j.chom.2018.03.019 CONTACT: Thijn R. Brummelkamp, Netherlands Cancer Institute, Amsterdam, the Netherlands email: t.brummelkamp@nki.nl Sandi Wong Netherlands Cancer Institute Kringle...
BioCentury | Jan 25, 2018
Targets & Mechanisms

Unexpected combinations

...on one of the studies and head of the Division of Molecular Oncology at the Netherlands Cancer Institute...
...have their own therapy response profile. That is another layer of personalized medicine.” Daniel Peeper, Netherlands Cancer Institute...
...when intra- or intertumoral heterogeneity is present. Intratumoral. In a Nature Medicine study, researchers from Netherlands Cancer Institute...
BioCentury | Jan 19, 2018
Company News

Desktop Genetics gets license to CRISPR analysis web tool

...U.K.) received exclusive worldwide rights to TIDE (Tracking of Indels by DEcomposition) technology from the Netherlands Cancer Institute...
...additional details. Netherlands Cancer Institute, Amsterdam, the Netherlands Desktop Genetics Ltd., London, U.K. Business: Cancer Shannon Lehnbeuter Desktop Genetics Ltd. Netherlands Cancer Institute...
Items per page:
1 - 10 of 88
BioCentury | Sep 23, 2020
Deals

Sept. 22 Quick Takes: Celgene CVR still in play; plus Dr. Reddy’s in Sputnik deal, $30M for Siolta, Amgen-Lilly, BioNTech-Novartis, Genentech-Scenic

...areas. Amsterdam-based Scenic, which is led by CEO Oscar Izeboud and spun out of the Netherlands Cancer Institute...
BioCentury | Sep 15, 2020
Finance

Cell therapy play Neogene’s $110M series A marks first investment for Tordjman’s Jeito Capital

...Vida, where Chang is an adviser. Linnemann, Neogene’s CEO, and Schumacher, who is a principal investigator at the Netherlands Cancer Institute...
BioCentury | Feb 22, 2019
Targets & Mechanisms

Expansion into TNBC

...if earlier examples carried the same risk. A 2018 study from a group at the Netherlands Cancer Institute...
...Francisco, Calif. Genmab A/S (CSE:GEN; Pink:GMXAY), Copenhagen, Denmark Merck & Co Inc. (NYSE:MRK), Kenilworth, N.J. Netherlands Cancer Institute...
BioCentury | Jan 9, 2019
Translation in Brief

T cells: Life after exhaustion?

...Weizmann Institute of Science and Netherlands Cancer Institute (NKI) scientists have shown dysfunctional T cells are not as...
...with high tumor reactivity. "We should not consider these cells inactive." Anne van der Leun, Netherlands Cancer Institute...
...CD274) - Programmed cell death 1 ligand 1; T cell receptor (TCR) Chris Lieu, Staff Writer Merck KGaA Netherlands Cancer Institute Weizmann...
BioCentury | Dec 20, 2018
Translation in Brief

Beyond T cell counts

...been focused on boosting overall T cell count in the tumor microenvironment, researchers at the Netherlands Cancer Institute...
...TCR profiling helps you to understand what the bottleneck is in tumor control.” Ton Schumacher, Netherlands Cancer Institute...
...tumor-reactive TCRs changes following treatment with immunotherapy. Schumacher said the work is unpatented. Alicia Parker, Staff Writer Netherlands Cancer Institute T...
BioCentury | Jun 7, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2018

...suggest inhibiting KREMEN1 alone or in combination with KREMEN2 could help treat coxsackie viral infections. Netherlands Cancer Institute...
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...the Netherlands Cell-seq mutagenesis screening platform to identify drug targets in a human cell line Netherlands Cancer Institute...
BioCentury | May 1, 2018
Distillery Therapeutics

Infectious disease

...online April 19, 2018 doi:10.1016/j.chom.2018.03.019 CONTACT: Thijn R. Brummelkamp, Netherlands Cancer Institute, Amsterdam, the Netherlands email: t.brummelkamp@nki.nl Sandi Wong Netherlands Cancer Institute Kringle...
BioCentury | Jan 25, 2018
Targets & Mechanisms

Unexpected combinations

...on one of the studies and head of the Division of Molecular Oncology at the Netherlands Cancer Institute...
...have their own therapy response profile. That is another layer of personalized medicine.” Daniel Peeper, Netherlands Cancer Institute...
...when intra- or intertumoral heterogeneity is present. Intratumoral. In a Nature Medicine study, researchers from Netherlands Cancer Institute...
BioCentury | Jan 19, 2018
Company News

Desktop Genetics gets license to CRISPR analysis web tool

...U.K.) received exclusive worldwide rights to TIDE (Tracking of Indels by DEcomposition) technology from the Netherlands Cancer Institute...
...additional details. Netherlands Cancer Institute, Amsterdam, the Netherlands Desktop Genetics Ltd., London, U.K. Business: Cancer Shannon Lehnbeuter Desktop Genetics Ltd. Netherlands Cancer Institute...
Items per page:
1 - 10 of 88